ENMD-2076 50mg

ENMD-2076 is a novel, orally-active antimitotic and antiangiogenic molecule inhibits Aurora A as well as tyrosine kinases that drive tumor vascularization, including VEGFR2 (KDR), PDGFR and the FGF receptors.

Price Not Available 50mg ENMD-2076 50mg Supplier Page

Trivial name	ENMD-2076 50mg
Catalog Number	A10352-50
Alternative Name(s)	(E)-N-(5-methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amine
Molecular Formula	C21H25N7
CAS#	934353-76-1, 1291074-87-7
SMILES	CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)/C=C/C4=CC=CC=C4
Size	50mg
Supplier Page	http://www.adooq.com/enmd-2076.html